New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

FDA Authorizes Moderna and JnJ Boosters

The agency will let vaccine recipients choose which vaccine they get as a booster, promoting mix-and-match.

According to a recent CNN article, the FDA officially authorized booster shots for COVID-19 vaccines. The authorization came last Wednesday, and it applies to the tens of millions of people who received Moderna’s double-dose vaccine, and Johnson & Johnson’s single-dose shot. Interestingly, the FDA is endorsing medical providers to employ a “mix and match” strategy that will give people booster shots from different vaccines than they received initially.

Experts believe the decision could lower interest in Johnson & Johnson’s vaccine, which has proven less protective than the other two in recent studies. Vaccine recipients will have the option of receiving either a Moderna or Pfizer-BioNTech booster. Dr. Janet Woodcock, the FDA’s acting commissioner, noted that the agency does not have preferential recommendations, and that if patients have questions they should consult their physicians.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts